Calton & Associates, Inc. Merck & Co., Inc. Transaction History

Calton & Associates, Inc.

  • $622 Million
  • Q3 2025

A detailed history of Calton & Associates, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Calton & Associates, Inc. holds 14,624 shares of MRK stock, worth $1.36 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
14,624
Previous 4,345 236.57%
Holding current value
$1.36 Million
Previous $343,000 257.73%
% of portfolio
0.2%
Previous 0.06%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
$77.6 - $87.37 $797,650 - $898,076
10,279 Added 236.57%
14,624 $1.23 Million
Q2 2025

Aug 12, 2025
SELL
$73.47 - $87.12 $8,008 - $9,496
-109 Reduced 2.45%
4,345 $343,000
Q1 2025

May 15, 2025
BUY
$83.01 - $101.02 $256,998 - $312,757
3,096 Added 227.98%
4,454 $399,000
Q1 2025

May 05, 2025
BUY
$83.01 - $101.02 $112,727 - $137,185
1,358 New
1,358 $121,000
Q3 2024

Oct 21, 2024
SELL
$111.15 - $128.97 $1.5 Million - $1.74 Million
-13,492 Reduced 75.03%
4,490 $509,000
Q3 2024

Oct 18, 2024
BUY
$111.15 - $128.97 $1.78 Million - $2.06 Million
16,007 Added 810.48%
17,982 $2.04 Million
Q2 2024

Jul 19, 2024
SELL
$123.8 - $132.96 $93,345 - $100,251
-754 Reduced 27.63%
1,975 $244,000
Q1 2024

Apr 16, 2024
SELL
$113.24 - $131.95 $153,666 - $179,056
-1,357 Reduced 33.21%
2,729 $360,000
Q4 2023

Feb 07, 2024
BUY
$100.18 - $109.02 $409,335 - $445,455
4,086 New
4,086 $445,000
Q2 2023

Jul 24, 2023
BUY
$108.61 - $118.38 $123,706 - $134,834
1,139 Added 30.78%
4,840 $558,000
Q1 2023

Apr 19, 2023
SELL
$102.94 - $114.86 $267,438 - $298,406
-2,598 Reduced 41.24%
3,701 $393,000
Q4 2022

Jan 18, 2023
BUY
$87.44 - $112.11 $185,372 - $237,673
2,120 Added 50.73%
6,299 $0
Q3 2022

Oct 31, 2022
SELL
$84.53 - $94.96 $7,861 - $8,831
-93 Reduced 2.18%
4,179 $359,000
Q2 2022

Jul 12, 2022
SELL
$83.49 - $94.64 $125,735 - $142,527
-1,506 Reduced 26.06%
4,272 $389,000
Q1 2022

Apr 12, 2022
SELL
$73.51 - $82.4 $196,712 - $220,502
-2,676 Reduced 31.65%
5,778 $474,000
Q4 2021

Jan 13, 2022
SELL
$72.28 - $90.54 $88,398 - $110,730
-1,223 Reduced 12.64%
8,454 $647,000
Q3 2021

Nov 05, 2021
SELL
$71.68 - $78.83 $115,763 - $127,310
-1,615 Reduced 14.3%
9,677 $726,000
Q2 2021

Aug 11, 2021
SELL
$70.31 - $77.77 $26,858 - $29,708
-382 Reduced 3.27%
11,292 $879,000
Q1 2021

May 03, 2021
SELL
$68.86 - $81.11 $215,462 - $253,793
-3,129 Reduced 21.14%
11,674 $900,000
Q4 2020

Jan 25, 2021
SELL
$71.77 - $79.65 $87,631 - $97,252
-1,221 Reduced 7.62%
14,803 $1.21 Million
Q3 2020

Oct 30, 2020
BUY
$73.18 - $82.95 $52,104 - $59,060
712 Added 4.65%
16,024 $1.33 Million
Q2 2020

Aug 10, 2020
BUY
$70.42 - $80.13 $61,758 - $70,274
877 Added 6.08%
15,312 $1.18 Million
Q1 2020

Apr 30, 2020
SELL
$63.36 - $87.82 $85,536 - $118,556
-1,350 Reduced 8.55%
14,435 $1.11 Million
Q4 2019

Feb 03, 2020
BUY
$77.58 - $87.54 $80,372 - $90,691
1,036 Added 7.02%
15,785 $1.44 Million
Q3 2019

Nov 07, 2019
BUY
$76.08 - $82.93 $23,889 - $26,040
314 Added 2.18%
14,749 $1.24 Million
Q2 2019

Jul 09, 2019
BUY
$69.84 - $81.59 $28,215 - $32,962
404 Added 2.88%
14,435 $1.21 Million
Q1 2019

Apr 25, 2019
SELL
$69.58 - $79.36 $348,943 - $397,990
-5,015 Reduced 26.33%
14,031 $1.17 Million
Q4 2018

Feb 11, 2019
BUY
$65.24 - $75.71 $186,325 - $216,227
2,856 Added 17.64%
19,046 $1.46 Million
Q3 2018

Oct 24, 2018
SELL
$57.69 - $67.84 $68,824 - $80,933
-1,193 Reduced 6.86%
16,190 $1.15 Million
Q2 2018

Aug 10, 2018
SELL
$50.83 - $59.72 $186,851 - $219,530
-3,676 Reduced 17.46%
17,383 $1.16 Million
Q1 2018

Apr 17, 2018
BUY
$50.96 - $59.23 $27,008 - $31,391
530 Added 2.58%
21,059 $1.15 Million
Q4 2017

Feb 05, 2018
BUY
$51.62 - $61.64 $1.06 Million - $1.27 Million
20,529
20,529 $1.27 Million

Others Institutions Holding MRK

# of Institutions
3,881
Shares Held
1.9B
Call Options Held
31.1M
Put Options Held
28.5M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $235B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Calton & Associates, Inc. Portfolio

Follow Calton & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Calton & Associates, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email